More than half of EU adults are overweight, while one in six is classified as obese; it’s a growing problem for healthcare ...

Novo Nordisk filed an FDA application for weekly CagriSema after trials showed up to 22.7% weight loss versus placebo.

The financial website Wallethub compared all 50 states and the District of Columbia to rank the most overweight and obese ...

The rising obesity trend is seriously worrying and requires urgent, dedicated and consistent intervention on both micro and macro scales.

Parents in Wiltshire might want to put the chocolates on a high shelf and keep an eye on the fizzy drinks this Christmas, ...

Eli Lilly (LLY) stock is in focus as the company posts late-stage trial data to indicate that its obesity pill orforglipron ...

A major review in Frontiers in Science highlights how tackling unsustainable food systems—reflected by our changing food ...

There is an increase in the number of referrals of children with obesity, growing waiting lists, and significantly more ...

Vets are exploring new medicines for overweight cats. These drugs mimic hormones that reduce appetite and improve glucose ...

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

Once-weekly tirzepatide is associated with clinically relevant reductions in SUA levels over 72 weeks, largely driven by substantial weight loss.

Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...